Drug Type Small molecule drug |
Synonyms SHR 902275, SHR902275 |
Target |
Action inhibitors |
Mechanism Raf kinase inhibitors(RAF serine/threonine protein kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H23F3N4O4 |
InChIKeyLRTINOCIDJSJPY-UHFFFAOYSA-N |
CAS Registry2695506-82-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | China | 07 Dec 2021 | |
| Neoplasms | Preclinical | China | 07 Dec 2021 |





